In the midst of a rising virus threat, Australia is witnessing a surge in Respiratory Syncytial Virus (RSV) cases, prompting a renewed call for older Australians to get vaccinated. This development is particularly concerning, as RSV has overtaken influenza as the most common respiratory virus this winter, marking the first time since national reporting began. The situation is so dire that health experts are urging eligible West Australians to take advantage of free RSV vaccines, warning that the virus can lead to serious illness, hospitalisation, and even death in older people.
One of the most striking aspects of this story is the personal impact it has on individuals like Diana Hamersley, an 82-year-old Perth woman who spent six weeks recovering from the virus last year. Her experience highlights the debilitating nature of RSV, which she describes as worse than COVID-19. This firsthand account underscores the urgency of the situation and the need for widespread vaccination.
The Mid-Winter RSV Report Card from the Immunisation Foundation of Australia reveals a concerning trend. More than 83,000 cases have already been recorded nationwide this year, with almost 900 new infections reported daily since winter began. RSV has surpassed both influenza and COVID-19 as Australia's leading respiratory virus this winter, marking a significant shift in the landscape of respiratory diseases.
Despite the alarming rise in cases, vaccine uptake remains well behind influenza. While over 1.76 million eligible older Australians have received a flu vaccine this year, only 722,530 have received the free RSV vaccine, leaving more than one million eligible people still unprotected. This disparity is largely due to the fact that the RSV vaccine has only been free for older Australians for two months, according to Catherine Hughes, the founder and executive director of the Immunisation Foundation of Australia.
The implications of this situation are far-reaching. RSV infects the lungs and airways, commonly causing coughing, fever, runny nose, and breathing difficulties. While many people experience mild symptoms, the virus can quickly become severe in older adults, infants, and people with underlying health conditions. Australian Medical Association WA president Dr Kyle Hoath points out that RSV can be deadly if it leads to pneumonia in vulnerable individuals, underscoring the critical need for vaccination.
The good news is that free RSV vaccinations are available for Australians aged 75 years and over, as well as Aboriginal and Torres Strait Islander people aged 60 years and over. However, the challenge lies in ensuring that these vaccines are accessible and widely accepted. Many people are unaware that they can receive their RSV and influenza vaccines at the same appointment, and the cost of the vaccine before it became free was about $300 a dose, which could be a significant barrier for many.
In Western Australia, 5044 RSV cases have been recorded so far this year, with 4172 (about 82%) in the Perth metropolitan area. The South West has recorded 349 cases, while the Kimberley has reported 198. These numbers highlight the regional disparities in the impact of RSV and the need for targeted vaccination efforts.
The story of RSV in Australia is a stark reminder of the ongoing threat of respiratory viruses and the importance of vaccination in mitigating their impact. It also underscores the need for better public health education and access to vaccines, particularly for older Australians who are most at risk. As we navigate the complexities of this situation, it is clear that a comprehensive approach to vaccination and public health awareness is essential to protecting the health and well-being of our communities.
